Skip to product information
1 of 1

Noggin Protein, Mouse

Noggin Protein, Mouse

Catalog Number: UA040404 Brand: UA BIOSCIENCE
Price:
Regular price $115 USD
Regular price Sale price $115 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Mouse
Synonyms Noggin
Accession P97466
Amino Acid Sequence

Gln28-Cys232

Expression System CHO
Molecular Weight

29-32 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Nature. 2000 Feb 10;403(6770):658-61.
Science. 1998 May 29;280(5368):1455-7.

Background

Mouse Noggin is a 64 kDa secreted homodimeric glycoprotein that functions as a potent antagonist of Bone Morphogenetic Protein (BMP) signaling. Encoded by the Nog gene, Noggin directly binds BMP ligands (BMP-2, -4, -5, -7) and Growth Differentiation Factors (GDF-5, -6) with high affinity, preventing their interaction with cognate receptors and subsequent downstream Smad-dependent signaling cascade activation. The protein is expressed in key developmental organizers including the node, notochord, dorsal somite, and roof plate, where it establishes gradients of BMP activity essential for patterning.
In the adult mouse brain, Noggin is expressed in the subventricular zone (SVZ) where it creates a neurogenic niche by antagonizing endogenous BMPs. This promotes neuronal differentiation of neural stem cells while suppressing astrocytic fate, thereby maintaining neurogenesis throughout adulthood.

Picture

Bioactivity

Measured by its ability to inhibit BMP-2-induced luciferase reporter activity in HEK293T human embryonic kidney cells. The EC50 for this effect is 64-77ng/mL in the presence of 100ng/mL Recombinant Human BMP-2.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

>95% as determined by RP-HPLC.